Company performance
Add to research
Current Price
as of Jun 18, 2025$11.12
P/E Ratio
N/A
Market Cap
$991.27M
Description
Add to research
Verve Therapeutics, Inc. is a genetic medicines company, which engages in the development of approach to the care of cardiovascular diseases. The company was founded by Burt A. Adelman, Keith J. Joung, Sekar Kathiresan, Kiran Musunuru, Anthony Philippakis, Issi Rozen, and Barry Ticho in 2018 and is headquartered in Boston, MA.
Metrics
Add to research
Overview
- HQBoston, MA
- SectorHealth Technology
- IndustryBiotechnology
- TickerVERV
- Price$11.12-2.28%
Trading Information
- Market cap$991.27M
- Float73.77%
- Average Daily Volume (1m)7,846,345
- Average Daily Volume (3m)5,181,062
- EPS-$2.11
Company
- Revenue$59.61M
- Rev growth (1yr)479.03%
- Net income-$31.03M
- Gross margin94.80%
- EBITDA margin-105.90%
- EBITDA-$34.92M
- EV-$22.64M
- EV/Revenue-0.38
- P/EN/A
- P/S16.56
- P/B2.09
- Debt/Equity14.50
Documents
Add to research
SEC Filings
Factset Street Account